65th ASH Annual Meeting & Exposition: Quality of Life, Burden of Illness, and Treatment Burden in Paroxysmal Nocturnal Hemoglobinuria: A Current Perspective on C5 Inhibitors

-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member

denotes an abstract that is clinically relevant.

denotes that this is a recommended PHD Trainee Session.

denotes that this is a ticketed session.

Quality of Life, Burden of Illness, and Treatment Burden in Paroxysmal Nocturnal Hemoglobinuria: A Current Perspective on C5 Inhibitors

Sponsor: Genentech, A Member of the Roche Group

Industry Theaters

Room 1A (San Diego Convention Center)

Speaker:

John Pasi, MD, PhD, Roche

Disclosures:

No relevant conflicts of interest to declare.

For In-Person Participants Only

See more of: Industry Theaters